- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Basilea Pharmaceutica+ Add to Watchlist
PK5:GR82.852 EUR 0.612 0.74%
As of 03:03:13 ET on 12/19/2013.
Company Profile for Basilea Pharmaceutica (PK5)
Basilea Pharmaceutica AG is a biotechnology company conducting research into the development of drugs for the treatment of infectious diseases and dermatological problems. The Company develops anti-bacterial and anti-fungal compounds which destroy infectious organisms.
Key Executives for Basilea Pharmaceutica (PK5)
|Martin NicklassonChairman||Domenico ScalaVice Chairman|
|Ronald Scott "Ron"Chief Executive Officer||Donato SpotaChief Financial Officer|
|Ingrid Heinze-KraussChief Technology Officer||Achim KaufholdChief Medical Officer|
|Laurenz KellenbergerChief Scientific Officer||Barbara ZinkHead:Corporate Development|